Recent reports of the detection of simian virus 40 (SV40) nucleotide sequences in ependymomas, choroid plexus tumors, osteosarcomas, and mesotheliomas have raised the possibility that SV40, which naturally infects Asian macaques, is circulating among humans. This possibility was examined by performing polymerase chain reaction assays on urine samples of 166 homosexual men, 88 of them human immunodeficiency virus (HIV) -seropositive, for genomic sequences of SV40 as well as of human polyomaviruses BK virus (BKV) and JC virus (JCV). Tests with masked urine specimens spiked with SV40-transformed cells were included to monitor the SV40 assay. SV40, BKV, and JCV sequences were identified, respectively, in 0, 14%, and 34% of the urine specimens. JCV viruria was far more common (37%) than BKV viruria (5%) in HIV-seronegative persons. HIV infection and more severe immunosuppression were associated with a higher frequency of BKV viruria. In summary, SV40 viruria was not detected among homosexual men who shed human polyomaviruses at a high frequency.
DNA sequences of simian virus 40 (SV40), a natural infecthe discovery of SV40 make it unlikely that any product administered after 1963 would have been contaminated with SV40 tion of Asian macaques, were recently reported to be present in several rare human cancers, including ependymomas and [7] . The US patients recently reported to have SV40-positive choroid plexus tumors (brain tumors) [1] , which typically occur in children õ5 years old, osteosarcomas [2] , which occur most ependymomas, choroid plexus tumors, and osteosarcomas were born many years after 1963 and were therefore at no risk of commonly in the first and second decade of life, and in pleural mesotheliomas [3] , which are asbestos-related cancers primaracquiring SV40 from contaminated vaccines. It has been suggested, as one possible explanation of these findings, that SV40 ily affecting men aged ú50. In addition, infectious SV40 was isolated from one ependymoma tissue [4] . In contrast to the might have become a human-adapted virus, capable of circulating efficiently in communities by person-to-person transmisabove findings, our study of mesotheliomas in US residents failed to detect SV40 in tumor tissues [5] .
sion, without the need for a nonhuman animal reservoir [1] . In this report, we have examined this possibility by testing urine It has remained unclear how the reported SV40-positive patients might have acquired SV40 infection [1 -3] . There is no specimens from immunosuppressed and nonimmunosuppressed persons for genomic sequences of SV40 as well as of known animal reservoir of SV40 in the United States. The only documented exposure of US residents to SV40 occurred the human polyomaviruses BK virus (BKV) and JC virus (JCV). The human polyomaviruses are frequently shed in urine between 1955 and 1963, principally to recipients of the inactivated poliovirus (Salk) vaccines [6, 7] . During this time period, [8] . It seemed probable that SV40, which is closely related to BKV and JCV and which remains latent in the kidneys of its experimental and licensed viral vaccines that used virus pools prepared in macaque kidney cultures were inadvertently connatural simian hosts, would be found in human urine, especially in urine of immunocompromised persons, if it were circulating taminated with SV40. Federal regulations put into effect after in the communities. was collected, were available [10] . The subjects were mostly white men were similar (age range, 28-69 years; median age, 39 for HIV-positive and 38 for HIV-negative men). The urine samples were processed by an independent laboratory under contract to the Viral Epidemiology Branch of the National Cancer Institute (NCI). The amount of urine available was 5-10 mL for 140 men, 3-5 mL for 23 men, and õ3 mL for 3 men. The specimens were centrifuged at 49,000 g for 4 h to pellet cells as well as free virus. The pellet was resuspended in 500 mL of distilled water by vortexing, and the tube was placed in an ultrasonic water bath to disrupt the cells. Each specimen was then aliquoted into three tubes and stored at 070ЊC.
Masked SV40-positive controls. To ensure that the tests were able to detect SV40, masked SV40-positive controls were prepared at the Johns Hopkins University laboratory by spiking a normal urine sample with a known number of SV40-transformed human cells, as follows. SV40-transformed human fibroblast WI26 cell line, purchased from the American Type Culture Collection (ATCC CCL95.1; Rockville, MD), was cultured in the laboratory. The cultured cells were trypsinized and counted with a hemocytometer, and 40,000 cells were placed into each of several 10-mL tubes that contained 6 mL of normal urine. These tubes were transported to the independent laboratory under NCI contract, where they were masked and processed in the same way as the urine samples from patients. About 10% of the samples sent to the Johns Hopkins University laboratory for polymerase chain reaction (PCR) assays were masked SV40-positive specimens. As described below, 5 mL of a 1 in 2 dilution of the processed specimen was used for each PCR assay. It was estimated that for the masked SV40-positive controls, that would represent 200 SV40-transformed cells.
Negative controls. Every 12th specimen in the test (column 7 in the filters in figure 1 ) was a negative control, consisting of 5000 K562 human cells.
PCR amplification and identification. PCR amplifications were done as described [5] in a 96-well thermocycler (PerkinElmer Cetus, Norwalk, CT). Amplification products were transferred to Biotrans(/) nylon filters (ICN, Costa Mesa, CA) and identified with biotinylated probes in the Amersham enhanced chemiluminescence system. Briefly, 100 mL of the specimen was digested with an equal amount of 400 mg/mL proteinase K; 5 mL of the digest was used for each Figure 1 . Hybridization of filters containing 75 specimens with PCR reaction. Two PCR amplifications were done: for SV40, using biotinylated probes to SV40 (filter A), JCV (filter B), and BKV (filter primers SV.For3 and SV.Rev, which amplify a 105-bp segment of C). Specimens are in same relative position on 3 filters, except for the T antigen region of SV40 [1] , and for BKV and JCV, using G11 and G12, which are hybridization controls. G11 and G12 on primers PEP-1 and PEP-2, which amplify a conserved, 218-bp segfilter A contain amplicons of SV40 and on filters B and C contain ment of T antigen of both viruses [11] . SV40 was identified with amplicons of BKV (G11) and of JCV (G12). Specimens in column probe sequence GGAAAGTCCTTGGGGTCTTCTACC [2] , BKV 7 are negative controls. 6 specimens that hybridize with SV40 in filter with probe BEP-1, and JCV with probe JEP-2 [11] .
A are all masked SV40-positive controls. Specimens A3, C6, and D9 contain both BKV and JCV. Statistical analysis. The DNA results were summarized in contingency tables and analyzed by standard x 2 statistics, including Fisher's exact test, or by the extended Mantel-Haenszel x 2 method, to test for trends [12] associated with HIV infection and CD4 cell BKV sequences were identified in 23 (14%) and JCV se- 
1). BKV shedding was uncommon in HIV-negative donors
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(5%), but it increased to 22% in HIV-positive donors (P Å .002; table 1). Moreover, in HIV-positive subjects, prevalence The patterns of hybridization with SV40, BKV, and JCV, of BKV DNA increased incrementally with greater immunoand the lack of cross-hybridization between the virus hybridization controls, are illustrated in figure 1 .
suppression, from a low of 18% in subjects with ú500 CD4 cells to a high of 27% in subjects with õ200 CD4 cells. The Both BKV and JCV were readily detected in the urine specimens. However, the two viruses showed different patterns of overall relation of BKV viruria with immune status (HIV infection and CD4 cell count) was highly statistically significant (P viruria. BKV shedding was infrequent in HIV-seronegative but common in HIV-seropositive patients, and in the latter group, Å .004), although this trend was not significant within the HIVpositive stratum.
the proportion of patients shedding BKV increased incrementally with greater immunosuppression. The same relationship The pattern of JCV shedding was quite different from that of BKV. In HIV-negative patients, JCV shedding was very between immunologic status and BKV viruria was reported by Markowitz et al. [14] . In contrast, JCV shedding was detected common (37%) and far more frequent than BKV shedding (37% vs. 4%; P õ .001). However, JCV shedding was not in about one-third of the patients regardless of HIV infection status and degree of immunosuppression, confirming a previous influenced by HIV infection status or by the degree of immunosuppression in HIV-positive persons. Adjustment for age in observation that in immune competent persons, JCV is shed more frequently than BKV [15] . multivariate analyses did not affect these findings for JCV or for BKV.
In contrast to the results with BKV and JCV, SV40 se-
